Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So,

Nancy J Devlin1, Tianxin Pan2, Mark Sculpher3

  • 1Health Economics Unit, Melbourne School of Population and Global Health, University of Melbourne, 207 Bouverie St, Melbourne, VIC, 3010, Australia. nancy.devlin@unimelb.edu.au.

Pharmacoeconomics
|July 13, 2023
PubMed

Insights

Value sets for pediatric health (EQ-5D-Y-3L) differ from adult sets, potentially due to wording or respondent perspectives. Understanding these differences is crucial for accurate economic evaluations in healthcare resource allocation.

Area of Science:

  • Health Economics
  • Pediatric Quality of Life Measurement
  • Psychometrics

Background:

  • Value sets for the EQ-5D-Y-3L (child-specific instrument) show distinct characteristics compared to adult EQ-5D value sets.
  • Key differences include higher values for the worst health states and fewer negative values in pediatric sets.

Purpose of the Study:

  • To investigate the reasons behind the differences between child and adult health values.
  • To explore the implications of these differences for using EQ-5D-Y-3L values in economic evaluations for healthcare resource allocation.

Main Methods:

  • The study posits four potential explanations for observed value set differences.
  • These include differences in descriptive severity, adult perceptions of child health, elicitation of preferences for others, and anchoring of 'dead=0' for child survival.

Main Results:

  • Existing evidence does not exclude upward bias in values due to eliciting preferences for others or child survival considerations.
  • These factors may influence the interpretation and application of pediatric health-related quality of life (HRQoL) values.

Conclusions:

  • Differences in EQ-5D-Y-3L value sets compared to adult sets necessitate careful consideration in economic evaluations.
  • Alternative, non-age-specific methods for valuing pediatric HRQoL may mitigate non-comparability issues.
  • Health technology assessment bodies must address specific considerations for child quality-adjusted life-year gains.

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
163
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
226
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
225